JPH03249756A - Ultra-high contrast negative image forming method - Google Patents
Ultra-high contrast negative image forming methodInfo
- Publication number
- JPH03249756A JPH03249756A JP4802290A JP4802290A JPH03249756A JP H03249756 A JPH03249756 A JP H03249756A JP 4802290 A JP4802290 A JP 4802290A JP 4802290 A JP4802290 A JP 4802290A JP H03249756 A JPH03249756 A JP H03249756A
- Authority
- JP
- Japan
- Prior art keywords
- silver halide
- high contrast
- ultra
- present
- negative image
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 39
- -1 silver halide Chemical class 0.000 claims abstract description 42
- 229910052709 silver Inorganic materials 0.000 claims abstract description 38
- 239000004332 silver Substances 0.000 claims abstract description 38
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims abstract description 21
- 239000000463 material Substances 0.000 claims abstract description 20
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 15
- 238000012545 processing Methods 0.000 claims abstract description 5
- 150000001875 compounds Chemical class 0.000 claims description 11
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- NVXLIZQNSVLKPO-UHFFFAOYSA-N Glucosereductone Chemical compound O=CC(O)C=O NVXLIZQNSVLKPO-UHFFFAOYSA-N 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 238000011161 development Methods 0.000 abstract description 5
- 229920000642 polymer Polymers 0.000 abstract description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract description 3
- 150000001298 alcohols Chemical class 0.000 abstract description 2
- 230000009467 reduction Effects 0.000 abstract description 2
- 235000002566 Capsicum Nutrition 0.000 abstract 2
- 239000006002 Pepper Substances 0.000 abstract 2
- 241000722363 Piper Species 0.000 abstract 2
- 235000016761 Piper aduncum Nutrition 0.000 abstract 2
- 235000017804 Piper guineense Nutrition 0.000 abstract 2
- 235000008184 Piper nigrum Nutrition 0.000 abstract 2
- VSTZVCJQGSLNLL-UHFFFAOYSA-N 2-aminophenyl hydrogen sulfate Chemical compound NC1=CC=CC=C1OS(O)(=O)=O VSTZVCJQGSLNLL-UHFFFAOYSA-N 0.000 abstract 1
- ZVNPWFOVUDMGRP-UHFFFAOYSA-N 4-methylaminophenol sulfate Chemical compound OS(O)(=O)=O.CNC1=CC=C(O)C=C1.CNC1=CC=C(O)C=C1 ZVNPWFOVUDMGRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 description 30
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 26
- 239000010410 layer Substances 0.000 description 18
- 239000000975 dye Substances 0.000 description 13
- 230000035945 sensitivity Effects 0.000 description 10
- 206010070834 Sensitisation Diseases 0.000 description 9
- 230000008313 sensitization Effects 0.000 description 9
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 8
- 239000000084 colloidal system Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 108010010803 Gelatin Proteins 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 5
- 229910021607 Silver chloride Inorganic materials 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000004848 polyfunctional curative Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 239000011593 sulfur Substances 0.000 description 4
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 150000002429 hydrazines Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000000206 photolithography Methods 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000011241 protective layer Substances 0.000 description 3
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 3
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 2
- ZFIQGRISGKSVAG-UHFFFAOYSA-N 4-methylaminophenol Chemical compound CNC1=CC=C(O)C=C1 ZFIQGRISGKSVAG-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- QUBQYFYWUJJAAK-UHFFFAOYSA-N oxymethurea Chemical compound OCNC(=O)NCO QUBQYFYWUJJAAK-UHFFFAOYSA-N 0.000 description 2
- 229950005308 oxymethurea Drugs 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 230000001235 sensitizing effect Effects 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 150000003536 tetrazoles Chemical class 0.000 description 2
- LUMLZKVIXLWTCI-NSCUHMNNSA-N (e)-2,3-dichloro-4-oxobut-2-enoic acid Chemical compound OC(=O)C(\Cl)=C(/Cl)C=O LUMLZKVIXLWTCI-NSCUHMNNSA-N 0.000 description 1
- AIGNCQCMONAWOL-UHFFFAOYSA-N 1,3-benzoselenazole Chemical class C1=CC=C2[se]C=NC2=C1 AIGNCQCMONAWOL-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- ODIRBFFBCSTPTO-UHFFFAOYSA-N 1,3-selenazole Chemical class C1=C[se]C=N1 ODIRBFFBCSTPTO-UHFFFAOYSA-N 0.000 description 1
- SIQZJFKTROUNPI-UHFFFAOYSA-N 1-(hydroxymethyl)-5,5-dimethylhydantoin Chemical compound CC1(C)N(CO)C(=O)NC1=O SIQZJFKTROUNPI-UHFFFAOYSA-N 0.000 description 1
- LKCHSNFSFPARNH-UHFFFAOYSA-N 2,3-dihydrothiophen-5-ol Chemical compound OC1=CCCS1 LKCHSNFSFPARNH-UHFFFAOYSA-N 0.000 description 1
- FITNPEDFWSPOMU-UHFFFAOYSA-N 2,3-dihydrotriazolo[4,5-b]pyridin-5-one Chemical class OC1=CC=C2NN=NC2=N1 FITNPEDFWSPOMU-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 1
- WSEFOZIMAJPJHW-UHFFFAOYSA-N 4-amino-2-(hydroxymethyl)phenol Chemical compound NC1=CC=C(O)C(CO)=C1 WSEFOZIMAJPJHW-UHFFFAOYSA-N 0.000 description 1
- LRUDIIUSNGCQKF-UHFFFAOYSA-N 5-methyl-1H-benzotriazole Chemical compound C1=C(C)C=CC2=NNN=C21 LRUDIIUSNGCQKF-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- PQUCIEFHOVEZAU-UHFFFAOYSA-N Diammonium sulfite Chemical compound [NH4+].[NH4+].[O-]S([O-])=O PQUCIEFHOVEZAU-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229910004042 HAuCl4 Inorganic materials 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- WRUZLCLJULHLEY-UHFFFAOYSA-N N-(p-hydroxyphenyl)glycine Chemical compound OC(=O)CNC1=CC=C(O)C=C1 WRUZLCLJULHLEY-UHFFFAOYSA-N 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 229910021612 Silver iodide Inorganic materials 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- QMJDEXCUIQJLGO-UHFFFAOYSA-N [4-(methylamino)phenyl] hydrogen sulfate Chemical compound CNC1=CC=C(OS(O)(=O)=O)C=C1 QMJDEXCUIQJLGO-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- HTKFORQRBXIQHD-UHFFFAOYSA-N allylthiourea Chemical compound NC(=S)NCC=C HTKFORQRBXIQHD-UHFFFAOYSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- XIWMTQIUUWJNRP-UHFFFAOYSA-N amidol Chemical compound NC1=CC=C(O)C(N)=C1 XIWMTQIUUWJNRP-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 150000001661 cadmium Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001844 chromium Chemical class 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- BBLSYMNDKUHQAG-UHFFFAOYSA-L dilithium;sulfite Chemical compound [Li+].[Li+].[O-]S([O-])=O BBLSYMNDKUHQAG-UHFFFAOYSA-L 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- QTNLQPHXMVHGBA-UHFFFAOYSA-H hexachlororhodium Chemical compound Cl[Rh](Cl)(Cl)(Cl)(Cl)Cl QTNLQPHXMVHGBA-UHFFFAOYSA-H 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002503 iridium Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000006224 matting agent Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- ZAKLKBFCSHJIRI-UHFFFAOYSA-N mucochloric acid Natural products OC1OC(=O)C(Cl)=C1Cl ZAKLKBFCSHJIRI-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002667 nucleating agent Substances 0.000 description 1
- 150000002916 oxazoles Chemical class 0.000 description 1
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 description 1
- 229940099427 potassium bisulfite Drugs 0.000 description 1
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 150000003236 pyrrolines Chemical class 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 150000003283 rhodium Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 1
- 229940045105 silver iodide Drugs 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 229940001607 sodium bisulfite Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- NVIFVTYDZMXWGX-UHFFFAOYSA-N sodium metaborate Chemical compound [Na+].[O-]B=O NVIFVTYDZMXWGX-UHFFFAOYSA-N 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- JAKYJVJWXKRTSJ-UHFFFAOYSA-N sodium;oxido(oxo)borane;tetrahydrate Chemical compound O.O.O.O.[Na+].[O-]B=O JAKYJVJWXKRTSJ-UHFFFAOYSA-N 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 150000003557 thiazoles Chemical class 0.000 description 1
- 150000003549 thiazolines Chemical class 0.000 description 1
- 150000003585 thioureas Chemical class 0.000 description 1
- 229940062627 tribasic potassium phosphate Drugs 0.000 description 1
- 229940001496 tribasic sodium phosphate Drugs 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Landscapes
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、ハロゲン化銀写真感光材料を用いて写真画像
を形成する方法に関する。さらに詳細には、特にグラフ
ィック・アープの印刷用写真製版工程に有用な極めて硬
調なネガチブ画像を形成する方法に関するもめである。DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a method of forming a photographic image using a silver halide photographic material. More specifically, the dispute relates to a method for forming extremely high contrast negative images, which are particularly useful in Graphic Arp's printing photolithography process.
(従来の技術)
写真製版工程に於てはシャープな網点画像あるいは線画
像の形成が要求されるため、極めて硬調な写真特性(特
にガンマが10以上)を示す画像形成システムが必要で
ある。(Prior Art) In the photoengraving process, it is required to form sharp halftone dot images or line images, so an image forming system that exhibits extremely high contrast photographic characteristics (in particular, a gamma of 10 or more) is required.
従来この目的のために、塩化銀の含有量が50モル%、
好ましくは70モル%をこえる塩臭化銀乳剤からなるリ
ス型ハロゲン化銀写真感光材料を、現像主薬としてハイ
ドロキノンのみを含む、遊離亜硫酸イオン濃度を極めて
低くした(通常0.1モル/l以下)リス現像液で処理
する方法が用いられてきた。しかし、リス型ハロゲン化
銀写真乳剤は塩化銀含有の高い塩臭化銀乳剤を用いなけ
ればならないため、高感度化の達成が困難であった。Conventionally, for this purpose, the content of silver chloride was 50 mol%,
A lithium-type silver halide photographic light-sensitive material comprising a silver chlorobromide emulsion preferably exceeding 70 mol % contains only hydroquinone as a developing agent and has an extremely low free sulfite ion concentration (usually 0.1 mol/l or less). A method of processing with a Lith developer has been used. However, since lithium-type silver halide photographic emulsions require the use of silver chlorobromide emulsions with high silver chloride content, it has been difficult to achieve high sensitivity.
硬調なネガチブ画像を得る別の方法としては、米国特許
第4.168.977号、同第4.224.401号、
同第4.241.164号、同第4.269.929号
、同第4、311.781号、同第4.650.746
号等に開示されている特定のヒドラジン誘導体を用いる
方法がある。Other methods for obtaining high contrast negative images include US Pat. No. 4.168.977, US Pat. No. 4.224.401,
4.241.164, 4.269.929, 4.311.781, 4.650.746
There is a method using a specific hydrazine derivative as disclosed in No. 1, et al.
この方法によれば、造核剤として特定のヒドラジン誘導
体(一般にアシルフェニルヒドラジン誘導体)を含有す
る表面潜像型ハロゲン化銀写真感光材料をpH11〜1
2.3の現像液で処理してガンマが10をこえる超硬調
で高い感度の写真特性が得られる。この方法では、臭化
銀や臭化銀含有量の高い塩臭化銀乳剤を用いることがで
きるのでリス型ハロゲン化銀乳剤に比べて高感度化を達
成することができた。According to this method, a surface latent image type silver halide photographic light-sensitive material containing a specific hydrazine derivative (generally an acylphenylhydrazine derivative) as a nucleating agent is prepared at a pH of 11 to 1.
When processed with a 2.3 developer, ultra-high contrast and high sensitivity photographic characteristics with a gamma of over 10 can be obtained. In this method, silver bromide or a silver chlorobromide emulsion with a high silver bromide content can be used, so higher sensitivity can be achieved compared to a lithium-type silver halide emulsion.
しかしながら、上記のアシルヒドラジン誘導体を用いる
硬調画像形成システムはいくつかの欠点を有することが
判ってきた。すなわち、上記の画像形成システムを用い
ると硬調なネガチブ画像が得られると同時にペラパー(
黒ボッ)の発生をともない写真製版工程上大きな問題と
なっている。However, high contrast imaging systems using the above-mentioned acylhydrazine derivatives have been found to have several drawbacks. In other words, by using the above image forming system, you can obtain a high-contrast negative image and at the same time
This is a major problem in the photolithography process due to the occurrence of black spots.
ペラパーというのは、未露光部、例えば網点と網点の間
の非現像部となるべき部分に発生する黒胡麻のようなス
ポットのことで、写真製版感材としての商品価値を著し
く低下させる故障を引き起す。Pellets are black sesame-like spots that occur in unexposed areas, such as areas between halftone dots that should be undeveloped, and significantly reduce the commercial value of photolithographic materials. cause a malfunction.
従って、ペラパー抑制技術の開発に多大の努力がなされ
ているが、ペラパーの改良が感度及びガンマの低下をも
たらすことが多く、ペラパー発生をともなわずに高感度
硬調化を達成する画像形成システムの開発が強く望まれ
ている。Therefore, a great deal of effort has been made to develop techniques for suppressing perturbation, but improvements in perturbation often result in a decrease in sensitivity and gamma, and the development of an image forming system that achieves high sensitivity and high contrast without the occurrence of perturbation. is strongly desired.
従来の硬調画像形成システムの第二の欠点として、現像
液の活性度を一定に保つために高価なハイドロキノンを
多量に用いなければならないことである。リス現像液は
液中の亜硫酸イオン濃度が低いため容易に空気酸化を受
は現像主薬であるハイドロキノンの消費が著しい。また
、ヒドラジン誘導体を用いる硬調画像形成システムの現
像液中には高濃度の亜硫酸塩を加えることが許容されて
いるが高pf((II〜12.3)であるため空気酸化
を受けやすくハイドロキノンの消費が著しい。従って、
これらの現像液の現像活性度を保持するためには高価な
ハイドロキノンを多量に用いたり、空気酸化によるハイ
ドロキノンの消費量を補充したりして現像液中のハイド
ロキノン量を一定水準以上に保つ必要があり、ハイドロ
キノンの消費量が少ないあるいは現像主薬としてハイド
ロキノンを使用しない現像液による硬調画像形成システ
ムの開発が望まれている。A second drawback of conventional high-contrast imaging systems is that large amounts of expensive hydroquinone must be used to maintain a constant developer activity. Since the lithium developer has a low concentration of sulfite ions, it is easily subject to air oxidation, resulting in significant consumption of hydroquinone, the developing agent. Furthermore, although it is permitted to add a high concentration of sulfite to the developer of a high-contrast image forming system that uses hydrazine derivatives, hydroquinone is susceptible to air oxidation due to its high pf ((II~12.3)). Consumption is significant. Therefore,
In order to maintain the development activity of these developers, it is necessary to maintain the amount of hydroquinone in the developer above a certain level by using a large amount of expensive hydroquinone or by replenishing the amount of hydroquinone consumed by air oxidation. Therefore, it is desired to develop a high-contrast image forming system using a developer that consumes less hydroquinone or does not use hydroquinone as a developing agent.
(発明が解決しようとする課題)
本発明が解決しようとする課題は、ハロゲン化銀写真感
光材料を現像主薬としてハイドロキノンを使用しない現
像液で処理することにより、ガンマが10をこえる極め
て硬調かつペラパー発生の少ないネガチブ画像の形成方
法を提供することにある。(Problems to be Solved by the Invention) The problems to be solved by the present invention are to achieve extremely high contrast and clear image with a gamma of over 10 by processing a silver halide photographic light-sensitive material with a developer that does not use hydroquinone as a developing agent. An object of the present invention is to provide a method for forming a negative image with less occurrence of negative images.
(課題を解決するための手段)
本発明の上記課題は、少なくとも(1)アミノフェノー
ル系現像主薬及び(2)レダクトン類とを含有する現像
液で、少くとも一種のポリアルキレンオキサイドまたは
その誘導体(以下、単にポリアルキレンオキサイド誘導
体と言う)の存在下に、露光された実質的に表面潜像型
のハロゲン化銀写真感光材料を現像処理することによっ
て達成された。(Means for Solving the Problems) The above object of the present invention is to provide a developer containing at least (1) an aminophenol developing agent and (2) reductones, and at least one polyalkylene oxide or a derivative thereof ( This was achieved by developing an exposed silver halide photographic material of substantially surface latent image type in the presence of a polyalkylene oxide derivative (hereinafter simply referred to as a polyalkylene oxide derivative).
本発明に使用されるポリアルキレンオキサイド誘導体と
しては、ポリエチレンオキサイド、ポリプロピレンオキ
サイドの如きポリアルキレンおよびポリエチレンオキサ
イドやポリプロピレンオキサイドなどのポリアルキレン
オキサイドと水、脂肪族アルコール類、フェノール類、
グリコール類、脂肪酸類、有機アミン類の群から選ばれ
た1種の化合物との付加重合物、またはポリアルキレン
オキサイドと上記化合物群から選ばれた1種の化合物と
の縮合物、または、種々のアルキレンオキサイド(例え
ばエチレンオキサイドとプロピレンオキサイド)相互の
ブロックコポリマーなどである。The polyalkylene oxide derivatives used in the present invention include polyalkylenes such as polyethylene oxide and polypropylene oxide, polyalkylene oxides such as polyethylene oxide and polypropylene oxide, water, aliphatic alcohols, phenols,
Addition polymers with one type of compound selected from the group of glycols, fatty acids, and organic amines, or condensates of polyalkylene oxide and one type of compound selected from the above group of compounds, or various These include mutual block copolymers of alkylene oxide (eg, ethylene oxide and propylene oxide).
また、本発明に使用されるポリアルキレンオキサイド誘
導体は数平均分子量が500〜20.000、特に好ま
しくは1.000〜10.000である。Further, the polyalkylene oxide derivative used in the present invention has a number average molecular weight of 500 to 20.000, particularly preferably 1.000 to 10.000.
次に本発明に用いられるポリアルキレンオキサイド誘導
体の若干の具体例を示す。Next, some specific examples of polyalkylene oxide derivatives used in the present invention will be shown.
P−I HO(CH2CH20)、、H(分子量的1
.000〜20.000P −2H(OCH2CH,)
1(CH2H20)。(CH2CH20)。HP−a
C+28+10(CH2CH20)z、HP−、
i C+5H3sO(CH2CH2O)zsHP
−5Cl8H330(CH2CH20)、。HP−6C
5H17+0(CH2CH20)20H−9
−fで
C*H+s ’)−0(CH2CH20)+00
8し
−10
Cl 1H23c00(CH2CH20)308P−1
3C,H,□CH”CH−C8H160(CH2CH2
0)16H)
本発明に使用されるポリアルキレンオキサイド誘導体は
、写真感光材料中または現像液中のいずれに含有させて
もよい。しかし、写真感光材料中に含有させる方がより
好ましい。P-I HO(CH2CH20),,H(molecular weight 1
.. 000~20.000P-2H(OCH2CH,)
1 (CH2H20). (CH2CH20). HP-a
C+28+10(CH2CH20)z, HP-,
i C+5H3sO(CH2CH2O)zsHP
-5Cl8H330 (CH2CH20),. HP-6C
5H17+0(CH2CH20)20H-9 -f at C*H+s')-0(CH2CH20)+00
8shi-10 Cl 1H23c00 (CH2CH20) 308P-1
3C, H, □CH"CH-C8H160 (CH2CH2
0) 16H) The polyalkylene oxide derivative used in the present invention may be contained in either the photographic material or the developer. However, it is more preferable to incorporate it into the photographic material.
ポリアルキレンオキサイド誘導体を写真感光材料中に含
有させるには該化合物を表面潜像型写真乳剤中に添加し
てもよいし、それ以外の親水性コロイド層から成る非感
光性層、例えば、保護層、中間層、ハレーション防止層
、フィルター層などの層中に添加してもよい。好ましい
のは、本発明に用いる表面潜像型写真乳剤に添加させる
ことである。本発明に用いられるポリアルキレンオキサ
イド誘導体を写真感光材料中に添加するには水又は水と
混和しつる有機溶媒、例えばアルコール類、ケトン類、
エステル類、アミド類などに溶解して本発明に用いる表
面潜像型写真乳剤もしくは非感光性の親水性コロイド溶
液に添加すればよい。In order to incorporate a polyalkylene oxide derivative into a photographic light-sensitive material, the compound may be added to a surface latent image type photographic emulsion, or a non-photosensitive layer consisting of another hydrophilic colloid layer, such as a protective layer. , an intermediate layer, an antihalation layer, a filter layer, and other layers. Preferably, it is added to the surface latent image type photographic emulsion used in the present invention. In order to add the polyalkylene oxide derivative used in the present invention to a photographic light-sensitive material, water or an organic solvent miscible with water, such as alcohols, ketones, etc.
It may be dissolved in esters, amides, etc. and added to the surface latent image type photographic emulsion or non-photosensitive hydrophilic colloid solution used in the present invention.
本発明に用いられるポリアルキレンオキサイド誘導体の
写真感光材料中への添加量はハロゲン化銀1モル当り0
.1 gから5gの範囲が適切であり、0.5gから3
gの範囲が特に好ましい。また、これらの化合物を添加
する時期は、写真感光材料を製造する工程中の任意の時
期を選ぶことができる。The amount of the polyalkylene oxide derivative used in the present invention added to the photographic light-sensitive material is 0 per mole of silver halide.
.. A range of 1 g to 5 g is appropriate, and 0.5 g to 3 g.
A range of g is particularly preferred. Further, the timing of adding these compounds can be selected at any time during the process of manufacturing the photographic material.
例えばハロゲン化銀乳剤層中に添加する場合には第2熟
成を終えた後塗布前までの任意の時期に添加するのが好
ましい。For example, when it is added to a silver halide emulsion layer, it is preferably added at any time after the second ripening and before coating.
なお、本発明に用いられるポリアルキレンオキサイド誘
導体は、本発明の現像液中に添加含有せしめても効果が
あり、この場合、現像液ll当り0.1gから5gを添
加すればよい。Note that the polyalkylene oxide derivative used in the present invention is effective even when added to the developer of the present invention, and in this case, it is sufficient to add 0.1 to 5 g per 1 liter of the developer.
本発明に使用する現像液にはアミノフェノール系現像主
薬が用いられる。アミノフェノール系現像主薬としては
4−アミノフェノール、4−(N−メチル)アミノフェ
ノール、2,4−ジアミノフェノール、N−(4−ヒド
ロキシフェニル)グリシン、2−(N−2’−ヒドロキ
シエチル)アミノフェノール、2−ヒドロキシメチル−
4−アミノフェノール、2−ヒドロキシメチル−4−(
N−メチル)アミノフェノールやこれらの化合物の塩酸
塩や硫酸塩などがあるが特に4−(N−メチル)アミノ
フェノール硫酸塩(メトール)が好ましい。これらの現
像主薬の添加量は現像液ll当り0.5〜10g、好ま
しくは1〜3gである。An aminophenol developing agent is used in the developer used in the present invention. Examples of aminophenol-based developing agents include 4-aminophenol, 4-(N-methyl)aminophenol, 2,4-diaminophenol, N-(4-hydroxyphenyl)glycine, and 2-(N-2'-hydroxyethyl). Aminophenol, 2-hydroxymethyl-
4-aminophenol, 2-hydroxymethyl-4-(
Examples include N-methyl)aminophenol, hydrochloride and sulfate of these compounds, and 4-(N-methyl)aminophenol sulfate (methol) is particularly preferred. The amount of these developing agents added is 0.5 to 10 g, preferably 1 to 3 g per liter of developer.
本発明に使用する現像液に用いられるレダクトン類は、
エンジオール型(Endiol)エナミノール型(En
aminol)、−r−ンジアミン型(Endiami
n)、チオールエノール型(Thiol−EnoJ)お
よびエナミン−チオール型(Enamin−Thiol
)が化合物として一般に知られている。これらの化合物
の例は米国特許第2、688.549号、特開昭62−
237443号なとに記載されている。これらのレダク
トン類の合成法もよく知られており、例えば野村男次と
大村法文共著「レダクトンの化学」 (内田老鶴圃新社
1969年)。The reductones used in the developer used in the present invention are:
Endiol type (Endiol) Enaminol type (En
aminol), -r-diamine type (Endiami
n), thiolenol type (Thiol-EnoJ) and enamine-thiol type (Enamin-Thiol
) is generally known as a compound. Examples of these compounds are U.S. Pat.
It is described in No. 237443. The methods for synthesizing these reductones are also well known, for example in ``The Chemistry of Reductones'' by Danji Nomura and Norifumi Omura (Uchida Rokakuba Shinsha, 1969).
に詳細に延べられている。is covered in detail.
この中でも、本発明に用いるのに特に好ましいレダクト
ン類は、次の一般式〔■〕で示される3カルボニル−エ
ンジオール型の化合物である。Among these, particularly preferred reductones for use in the present invention are 3-carbonyl-enediol type compounds represented by the following general formula [■].
聞
ここでRは水素原子または水酸基であり、nは1から4
の整数である。Here, R is a hydrogen atom or a hydroxyl group, and n is 1 to 4.
is an integer.
次に本発明に用いられるレダクトン類の特に好ましい具
体例をあげる。Next, particularly preferred specific examples of reductones used in the present invention will be given.
■
■
コ
聞
−2
■
−4
■
I−1
■
聞
I[−2
1−4
H
本発明に用いられるレダクトン類はリチウム塩、ナトリ
ウム塩、カリウム塩などのアルカリ金属塩の形でも使用
できる。これらのレダクトン類は、現像液11当り1〜
50g1好ましくは5〜20g用いるのが好ましい。■■Kobun-2 ■-4 ■I-1 ■KibunI [-2 1-4 H The reductones used in the present invention can also be used in the form of alkali metal salts such as lithium salts, sodium salts, and potassium salts. These reductones are used in an amount of 1 to 1 per 11 parts of the developer.
It is preferable to use 50 g, preferably 5 to 20 g.
本発明に用いる現像液には前記必須成分以外に保恒剤及
びアルカリを含むことが望ましい。保恒剤としては亜硫
酸塩を用いることができる。亜硫酸塩としては、亜硫酸
ナトリウム、亜硫酸カリウム、亜硫酸リチウム、亜硫酸
アンモニウム、重亜硫酸ナトリウム、重亜硫酸カリウム
、メタ重亜硫カリウムなどがある。これらの亜硫酸塩の
添加量は現像液11当り0.2モル以下、特に0.1モ
ル以下が好ましい。It is desirable that the developer used in the present invention contains a preservative and an alkali in addition to the above-mentioned essential components. Sulfites can be used as preservatives. Sulfites include sodium sulfite, potassium sulfite, lithium sulfite, ammonium sulfite, sodium bisulfite, potassium bisulfite, potassium metabisulfite, and the like. The amount of these sulfites added is preferably 0.2 mol or less, particularly 0.1 mol or less per developer.
アルカリは現像液のpHを9以上、特に好ましくはpH
1o−11に設定するために加えられる。pH設定のた
めに用いるアルカリ剤には通常の水溶性無機アルカリ金
属塩、例えば、水酸化ナトリウム、水酸化カリウム、炭
酸ナトリウム、炭酸カリウム、第三リン酸カリウムなど
を用いることができる。The alkali is used to adjust the pH of the developer to 9 or higher, particularly preferably to a pH of 9 or higher.
Added to set to 1o-11. As the alkaline agent used for pH setting, common water-soluble inorganic alkali metal salts such as sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, and tribasic potassium phosphate can be used.
本発明に使用する現像液は、上記成分の他に必要に応じ
て、水溶性の酸(例えば酢酸、ホウ酸)、pH緩衝剤(
例えば炭酸ナトリウム、炭酸カリウム、第三リン酸ナト
リウム、メタホウ酸ナトリウム)、無機カブリ抑制剤(
例えば臭化ナトリウム、臭化カリウム)、有機カブリ抑
制剤(例えば、l−フェニル−5−メルカプトテトラゾ
ール)、有機溶剤(例えばエチレングリコール、ジエチ
レングリコール、メチルセロソルブ)、を含有してもよ
く、更に必要に応じて色調剤、界面活性剤、消泡剤、硬
水軟化剤などを含有してもよい。In addition to the above-mentioned components, the developer used in the present invention may optionally contain a water-soluble acid (e.g. acetic acid, boric acid), a pH buffer (
For example, sodium carbonate, potassium carbonate, tribasic sodium phosphate, sodium metaborate), inorganic fog suppressants (
For example, sodium bromide, potassium bromide), organic fog suppressants (for example, l-phenyl-5-mercaptotetrazole), organic solvents (for example, ethylene glycol, diethylene glycol, methyl cellosolve), etc. Depending on the situation, it may contain a toning agent, a surfactant, an antifoaming agent, a water softener, etc.
現像処理温度は18〜50℃の範囲が選ばれるがより好
ましくは20〜40℃の範囲である。The developing treatment temperature is selected to be in the range of 18 to 50°C, more preferably in the range of 20 to 40°C.
本発明の現像処理方法により、現像主薬として高価なハ
イドロキノンを全く使用することなくペラパー発生の少
ない超硬調かつ高感度の写真特性が得られるようになる
。The development method of the present invention makes it possible to obtain ultra-high contrast and high sensitivity photographic properties with less occurrence of blur without using any expensive hydroquinone as a developing agent.
次に本発明の画像形成方法を適用するハロゲン化銀写真
感光材料について説明する。Next, a silver halide photographic material to which the image forming method of the present invention is applied will be explained.
本発明に用いられるハロゲン化銀写真感光材料は実質的
に表面潜像型のハロゲン化銀乳剤からなる乳剤層を少な
くとも一層有するものである。ここで実質的に表面潜像
型のハロゲン化銀乳剤とは、潜像が主として粒子表面に
形成されるタイプのハロゲン化銀乳剤を意味し、内部潜
像型のハロゲン化銀乳剤に対立する性質を有するもので
ある。The silver halide photographic material used in the present invention has at least one emulsion layer consisting essentially of a surface latent image type silver halide emulsion. Here, the term "substantially surface latent image type silver halide emulsion" refers to a type of silver halide emulsion in which a latent image is mainly formed on the grain surface, which is in contrast to an internal latent image type silver halide emulsion. It has the following.
使用するハロゲン化銀乳剤のハロゲン組成には特別な限
定はなく、塩化銀、塩臭化銀、沃臭化銀、法具塩化銀な
ど、どの組成であってもかまわない。There is no particular limitation on the halogen composition of the silver halide emulsion used, and any composition such as silver chloride, silver chlorobromide, silver iodobromide, silver chloride, etc. may be used.
沃化銀の含有は5モル%以下で、さらに3モル%以下で
あることが好ましい。The content of silver iodide is 5 mol% or less, more preferably 3 mol% or less.
本発明に用いられるハロゲン化銀粒子は、比較的広い粒
子サイズ分布をもつこともできるが、せまい粒子サイズ
分布をもつことが好ましく、特に全粒子の90%を占め
る粒子サイズが平均粒径の±40%以内にある単分散乳
剤であることが好ましい。Although the silver halide grains used in the present invention can have a relatively wide grain size distribution, it is preferable to have a narrow grain size distribution, and in particular, the grain size that accounts for 90% of all grains is within ± It is preferable that the emulsion is monodispersed within 40%.
本発明に用いられるハロゲン化銀粒子は、平均粒径が0
.7μ以下が好ましく、特に0.4μ以下が好ましい。The silver halide grains used in the present invention have an average grain size of 0.
.. The thickness is preferably 7μ or less, particularly preferably 0.4μ or less.
また、ハロゲン化銀粒子は立方体、八面体のような規則
的な結晶形を有するものでも、球状、板状のような変則
的な結晶形を有するものでもよい。Further, the silver halide grains may have a regular crystal shape such as a cube or an octahedron, or may have an irregular crystal shape such as a spherical shape or a plate shape.
本発明に用いられるハロゲン化銀粒子は任意の公知の方
法を用いて調製することができる。すなわち、酸性法、
中性法、アンモニア法などのいずれでもよく可溶性銀塩
と可溶性ノ10ゲン塩の反応形式としては順混合法、逆
混合法、同時混合法、それらの組合せなどのいずれを用
いてもよい。同時混合法の一つとして、ハロゲン化銀の
生成される液相中の銀イオン濃度(pAg)を一定に保
つ方法、すなわち、14gコンドロールド・ダブルジェ
ット法(C,D、J法)を用いると結晶形が揃い、かつ
粒子サイズが均一に近い単分散ハロゲン化銀粒子が得ら
れる。ハロゲン化銀粒子形成または物理熟成の過程にお
いてハロゲン化銀乳剤のコントラストを増大させるため
にカドミウム塩、イリジウム塩又はロジウム塩を共存さ
せてもよい。Silver halide grains used in the present invention can be prepared using any known method. i.e. acid method,
Either the neutral method or the ammonia method may be used, and the reaction method for the soluble silver salt and the soluble silver salt may be a forward mixing method, a back mixing method, a simultaneous mixing method, or a combination thereof. As one of the simultaneous mixing methods, a method of keeping the silver ion concentration (pAg) in the liquid phase in which silver halide is produced constant, that is, a 14g Chondrold double jet method (C, D, J method) is used. Monodisperse silver halide grains with uniform crystal shape and nearly uniform grain size can be obtained. In order to increase the contrast of the silver halide emulsion during the process of silver halide grain formation or physical ripening, a cadmium salt, iridium salt or rhodium salt may be present.
本発明に用いるハロゲン化銀写真乳剤層に含まれるバイ
ンダーはハロゲン化銀1モル当り250gをこえないこ
とが好ましい。バインダーとしてはゼラチンが最も好ま
しいがゼラチン以外の親水性コロイドを用いることもで
きる。例えば、アルブミン、カゼイン、ゼラチンと他の
高分子とのグラフトポリマー、ポリビニルアルコール、
ポリアクリルアミドなどの親水性ポリマーなどを用いる
ことができる。The binder contained in the silver halide photographic emulsion layer used in the present invention preferably does not exceed 250 g per mole of silver halide. Gelatin is most preferred as the binder, but hydrophilic colloids other than gelatin can also be used. For example, albumin, casein, graft polymers of gelatin and other polymers, polyvinyl alcohol,
Hydrophilic polymers such as polyacrylamide can be used.
本発明に用いるハロゲン化銀乳剤は化学増感を行なわな
くともよいが、通常は化学増感される。Although the silver halide emulsion used in the present invention does not need to be chemically sensitized, it is usually chemically sensitized.
化学増感法として硫黄増感、還元増感、貴金属増感及び
それらの組合せが用いられるが本発明の実施のために特
に好ましい化学増感は硫黄増感法あるいは硫黄増感と貴
金属増感の一つである金増感を組合せた方法である。As the chemical sensitization method, sulfur sensitization, reduction sensitization, noble metal sensitization, and combinations thereof are used, and particularly preferred chemical sensitization for carrying out the present invention is the sulfur sensitization method or the combination of sulfur sensitization and noble metal sensitization. This method combines one method, gold sensitization.
硫黄増感剤としては活性ゼラチン、チオ硫酸塩、チオ尿
素類、アリルチオカルバミドなどを用いることができる
。金増感剤としてはHAuCl4゜A、(SCN)2−
塩、肌(S203)2”−塩などを用いるこことができ
る。As the sulfur sensitizer, active gelatin, thiosulfate, thioureas, allylthiocarbamide, etc. can be used. As a gold sensitizer, HAuCl4゜A, (SCN)2-
Salt, skin (S203) 2''-salt, etc. can be used.
本発明に用いるハロゲン化銀乳剤は、所望の感光波長域
に感光性を付与するために、一種また二種以上の増感色
素を用いて分光増感される。増感色素としてはシアニン
色素、メロシアニン色素、スチリル色素、ヘミシアニン
色素、ホロポーラ−ジアニン色素、オキシツール色素、
およびヘミオキソノール色素などを用いることができる
。特に有用な色素はシアニン色素及びメロシアニン色素
である。色素類の塩基性異部環核としてシアニン色素に
通常利用される核はいずれも適用できる。The silver halide emulsion used in the present invention is spectrally sensitized using one or more sensitizing dyes in order to impart photosensitivity in a desired wavelength range. Sensitizing dyes include cyanine dyes, merocyanine dyes, styryl dyes, hemicyanine dyes, holopolar dianine dyes, oxytool dyes,
and hemioxonol dyes, etc. can be used. Particularly useful dyes are cyanine dyes and merocyanine dyes. As the basic heterocyclic nucleus of pigments, any nucleus commonly used for cyanine dyes can be used.
すなわち、ピロリン核、オキサゾール核、オキサプリン
核、チアゾール核、チアゾリン核、ピロール核、セレナ
ゾール核、イミダゾール核、テトラゾール核、ピリジン
核、インドール核、ベンズオキサゾール、ベンゾチアゾ
ール核、ベンゾセレナゾール核、ベンズイミダゾール核
、キノリン核などが適用できる。Namely, pyrroline nucleus, oxazole nucleus, oxaprine nucleus, thiazole nucleus, thiazoline nucleus, pyrrole nucleus, selenazole nucleus, imidazole nucleus, tetrazole nucleus, pyridine nucleus, indole nucleus, benzoxazole, benzothiazole nucleus, benzoselenazole nucleus, benzimidazole nucleus. , quinoline nucleus, etc. can be applied.
本発明に係るハロゲン化銀写真感光材料は支持体上に実
質的に表面潜像型のハロゲン化銀乳剤を含有する少なく
とも1つの親水性コロイド層を塗設して成るが、それ以
外の非感光性の親水性コロイド層例えば、保護層、中間
層、ハレーション防止層、フィルター層、などが塗設さ
れていてもよい。これらの親水性コロイド層には無機又
は有機の硬膜剤を含有してよい。硬膜剤としてはクロム
塩(クロム明ばんなど)、アルデヒド類(ホルムアルデ
ヒド、グリオキサールなど)、N−メチロール化合物(
ジメチロール尿素、メチロールジメチルヒダントインな
ど)、活性ハロゲン化合物(2,4−ジクロル−6−ヒ
ドロキシ−8−トリアジン、ムコクロール酸など)、活
性ビニル化合物(1,3,5−トリアクリロイル−へキ
サヒトローs−トリアジンなど)、エポキシ及びアジリ
ジン系硬膜剤などを用いることができる。The silver halide photographic light-sensitive material according to the present invention is formed by coating on a support at least one hydrophilic colloid layer containing a substantially surface latent image type silver halide emulsion, and other non-photosensitive materials. A hydrophilic colloid layer such as a protective layer, an intermediate layer, an antihalation layer, a filter layer, etc. may be coated. These hydrophilic colloid layers may contain inorganic or organic hardeners. Hardeners include chromium salts (chromium alum, etc.), aldehydes (formaldehyde, glyoxal, etc.), N-methylol compounds (
dimethylol urea, methylol dimethyl hydantoin, etc.), active halogen compounds (2,4-dichloro-6-hydroxy-8-triazine, mucochloric acid, etc.), active vinyl compounds (1,3,5-triacryloyl-hexahytrose-s-triazine) etc.), epoxy and aziridine hardeners, and the like can be used.
本発明に用いられる上記親水性コロイド層には必要に応
じて各種写真用添加剤、例えば乳剤安定剤(6−ヒドロ
キシ−4−メチル−1,3,3a。The hydrophilic colloid layer used in the present invention may optionally contain various photographic additives, such as an emulsion stabilizer (6-hydroxy-4-methyl-1,3,3a).
7−テトラザインデンなどのヒドロキシテトラザインデ
ン化合物)、延展剤(サポニンなど)、セラチン可塑剤
(アクリル酸エステルの共重合体など)、帯電防止、塗
布助剤、および写真特性改良(たとえば現像促進、硬調
化)など種々の目的のための各種界面活性剤(カチオン
性、アニオン性、非イオン性、両性界面活性剤)、カブ
リ抑制剤(ハイドロキノン、5−メチルベンゾトリアゾ
ール、■−フェニルー5−メルカプトテトラゾールなど
)、マット剤、写真感光材料の寸度安定性の改良などの
目的で水不溶または難溶性ポリマーラテックス(アルキ
ルアクリレート、アルキルメタアクリレート、アクリル
酸、グリシジルアクリレートなどのホモ又はコポリマー
)などを本発明の効果が損われない範囲で使用すること
ができる。hydroxytetrazaindene compounds such as 7-tetrazaindene), spreading agents (such as saponins), ceratin plasticizers (such as copolymers of acrylic acid esters), antistatic agents, coating aids, and photographic property improvements (e.g., development acceleration). Various surfactants (cationic, anionic, nonionic, amphoteric surfactants) for various purposes such as (high contrast, high contrast), fog suppressants (hydroquinone, 5-methylbenzotriazole, ■-phenyl-5-mercapto) tetrazole, etc.), matting agents, and water-insoluble or sparingly soluble polymer latexes (homo- or copolymers of alkyl acrylate, alkyl methacrylate, acrylic acid, glycidyl acrylate, etc.) for the purpose of improving the dimensional stability of photographic materials. It can be used as long as the effect of the invention is not impaired.
(実施例)
以下に実施例を示して本発明をさらに具体的に説明する
が本発明はその要旨を越えない限り、以下の実施例に限
定されるものではない。(Examples) The present invention will be described in more detail below with reference to Examples, but the present invention is not limited to the following Examples unless it exceeds the gist thereof.
実施例1〜5及び比較例1.2
40℃に保ったセラチン水溶液中に、硝酸銀水溶液と銀
1モル当り7.5X10−”モルの6塩化ロジウム[I
II)ナトリウムを含む臭化カリウムと塩化ナトリウム
の混合水溶液をpAg 7.2に保ちながら同時に75
分間に亘って加えることにより平均粒径0.28μの立
方晶単分散塩臭化銀乳剤CAgCf! : 70モル
%)を調製した、常法により可溶性塩類を除去した後、
ハロゲン化銀1モル当り4X10−5モルのチオ硫酸ナ
トリウム及びlXl0−5モルの塩化金酸を加え48℃
で60分間化学熟成した。これを乳剤Aとする。この乳
剤にはハロゲン化銀1モル当り80gのゼラチンを含む
。臭化カリウムと塩化ナトリウムの混合水溶液にさらに
沃化カリウムを加えるほかは乳剤Aと全く同じ方法でA
gl O,1モル%含有する沃塩臭化銀乳剤B (Ag
C12/AgBr、モル比: 70/30)を調製した
。Examples 1 to 5 and Comparative Example 1.2 A silver nitrate aqueous solution and 7.5×10-” mol of rhodium hexachloride [I
II) While keeping the pAg of a mixed aqueous solution of potassium bromide and sodium chloride containing sodium at 7.2, at the same time 75
By adding the cubic crystal monodisperse silver chlorobromide emulsion CAgCf with an average grain size of 0.28 μm over a period of 1 minute. : 70 mol%) was prepared, and after removing soluble salts by a conventional method,
Add 4X10-5 moles of sodium thiosulfate and 1X10-5 moles of chloroauric acid per mole of silver halide at 48°C.
Chemically aged for 60 minutes. This is called emulsion A. This emulsion contains 80 g of gelatin per mole of silver halide. Emulsion A was prepared in exactly the same manner as Emulsion A, except that potassium iodide was further added to the mixed aqueous solution of potassium bromide and sodium chloride.
Silver iodochlorobromide emulsion B (Ag
C12/AgBr, molar ratio: 70/30) was prepared.
このようにして調製した乳剤にハロゲン化銀1モル当り
6X10−3モルの6−ヒトロキシー4−メチル−1,
3,3a、 7−テトラザインデン。The emulsion thus prepared contains 6X10-3 moles of 6-hydroxy-4-methyl-1 per mole of silver halide,
3,3a,7-tetrazaindene.
3.5X10−’モルの3.3′−ジメチルテアゾリノ
カルボシアニンメチルサルフエート、カブリ抑制剤とし
てハイドロキノン5X10−2モル及び表1に示すよう
に本発明のポリアルキレンオキサイド誘導体をそれぞれ
添加した後、ポリエチレンテレフタレート(PET)ベ
ース上に1000rj当り40■の銀量になるよう塗布
した。この乳剤層を硬膜剤としてホルマリン及びジメチ
ロール尿素を含むゼラチン保護層によって保護した。After addition of 3.5 x 10-' moles of 3.3'-dimethyltheazolinocarbocyanine methyl sulfate, 5 x 10-2 moles of hydroquinone as a fog inhibitor and the polyalkylene oxide derivatives of the invention as shown in Table 1, respectively. , and coated on a polyethylene terephthalate (PET) base at a silver content of 40 silver per 1000 rj. This emulsion layer was protected by a gelatin protective layer containing formalin and dimethylol urea as hardeners.
上述のようにして作製したフィルムのサンプルをLB−
200及びND−10フイルターを用い、2666にの
タングステン光源にて段差0.15のステップウェッジ
を通して10秒間露光した後、本発明による下記組成の
現像液を用いて20℃で5分間現像し、停止、定着、水
洗、乾燥した。The sample of the film produced as described above was LB-
Using a 200 and ND-10 filter, the film was exposed for 10 seconds using a 2666 tungsten light source through a step wedge with a height difference of 0.15, and then developed at 20°C for 5 minutes using a developer with the following composition according to the present invention, and then stopped. , fixed, washed and dried.
現像液
メトール 2.5gアスコルビン
酸ナトリウム 10.0 g(I−1のナトリウム
塩)
臭化カリウム 1.0gメタホウ酸
ナナトリウム4水塩 35. Og水を加えて
1.01pH10,8
得られた写真特性を表1に示す。表1で相対感度はカブ
リを除く濃度3.0が得られる露光量の逆数の相対値で
、比較例1の値を100として示したものである。ガン
マ(γ)はカブリを除く黒化濃度0.5と3.0の間の
平均勾配で示した。また、ペラパーはフィルの非露光部
を50倍のルーペで観察し、5段階に評価したものでA
が最も良い品質(実質的にペラパー発生がない)を表わ
し、Eが最も悪い品質を表わす。A、 Bが実用に適し
、Cは低品位ながら何とか実用許容範囲内であり、D、
Eは実用不可能である。Developer solution Metol 2.5g Sodium ascorbate 10.0g (sodium salt of I-1) Potassium bromide 1.0g Sodium metaborate tetrahydrate 35. Add Og water
1.01 pH 10.8 The photographic properties obtained are shown in Table 1. In Table 1, the relative sensitivity is the relative value of the reciprocal of the exposure amount that provides a density of 3.0 excluding fog, and is shown with the value of Comparative Example 1 as 100. Gamma (γ) is expressed as an average slope between blackening density 0.5 and 3.0 excluding fog. In addition, the Peraper evaluation is made by observing the unexposed part of the fill with a 50x magnifying glass and rating it on a 5-point scale.
represents the best quality (substantially no sluggishness), and E represents the worst quality. A and B are suitable for practical use, C is low quality but somehow within the practical tolerance range, D,
E is impractical.
表1から明らかなように、ポリアルキレンオキサイド誘
導体が添加されていない比較例1及び2を本発明の現像
液で現像しても低ガンマで硬調画像は得られない。一方
、本発明のポリアルキレンオキサイド誘導体を添加した
実施例1. 2. 3゜4.5は本発明の現像液により
、ガンマが10を越える極めて高いコントラストと高い
感度が得られ、かつペラパー発生が認められない。As is clear from Table 1, even when Comparative Examples 1 and 2, to which no polyalkylene oxide derivative was added, were developed with the developer of the present invention, no high-contrast images with low gamma were obtained. On the other hand, Example 1 in which the polyalkylene oxide derivative of the present invention was added. 2. 3°4.5, the developer of the present invention provides extremely high contrast with a gamma of over 10 and high sensitivity, and no occurrence of perturbation is observed.
実施例6〜11及び比較例3〜7
実施例4のフィルムサンプルを実施例4と同様に露光し
た後、表2に示した各実施例及び比較例の現像液により
20℃で5分間現像し、実施例4と同様の方法で写真特
性値を求めた。得られた結果を表3に示す。表3で相対
感度は比較例7(市販品現像液コダックD−11の場合
)を100として示したものである。Examples 6 to 11 and Comparative Examples 3 to 7 The film samples of Example 4 were exposed in the same manner as in Example 4, and then developed at 20°C for 5 minutes with the developer of each Example and Comparative Example shown in Table 2. , photographic characteristic values were determined in the same manner as in Example 4. The results obtained are shown in Table 3. In Table 3, the relative sensitivity is shown with Comparative Example 7 (commercially available developer Kodak D-11) set as 100.
?
表3から明らかなように、実施例6〜11の場合にはガ
ンマが15を越える極めて硬調かつ高感度でペラパー発
生のない画像が形成されており、ポリアルキレンオキサ
イド誘導体を現像液中にも添加することにより(実施例
8)−層好ましい結果を与えることがわかる。一方、比
較例3〜7の現像液で現像しても硬調画像は得られない
。? As is clear from Table 3, in Examples 6 to 11, images with extremely high contrast and high sensitivity with a gamma exceeding 15 and no blurring were formed, and the polyalkylene oxide derivative was also added to the developer. It can be seen that (Example 8) - layer gives favorable results. On the other hand, high-contrast images cannot be obtained even when developed with the developers of Comparative Examples 3 to 7.
(発明の効果)
本発明の画像形成法によれば、ガンマが10をこえる極
めて硬調かつペラパー発生の少ないネガチブ画像を形成
することができ、特に印刷用写真製版に有効な高品質画
像を得ることができる。(Effects of the Invention) According to the image forming method of the present invention, it is possible to form a negative image with a gamma exceeding 10, extremely high contrast, and less occurrence of blur, and to obtain a high-quality image that is particularly effective for photolithography for printing. I can do it.
Claims (1)
画像露光後、現像処理して超硬調ネガ画像を形成する方
法において、一種以上のポリアルキレンオキサイドまた
はその誘導体の存在下に少なくとも下記2成分を含む現
像液で処理することを特徴とする超硬調ネガ画像の形成
方法。 (1)アミノフェノール系現像主薬 (2)レダクトン類 2、レダクトン類が一般式〔 I 〕で表わされる化合物
又はその塩である請求項1記載の超硬調ネガ画像の形成
方法。 一般式 I ▲数式、化学式、表等があります▼ (式中、Rは水素原子又は水酸基、nは1〜4の整数を
表わす。) 3、レダクトン類が一般式〔II〕で表わされる化合物又
はその塩である請求項1記載の超硬調ネガ画像の形成方
法。 一般式II▲数式、化学式、表等があります▼[Scope of Claims] 1. A method for forming an ultra-high contrast negative image by imagewise exposing and developing a substantially surface latent image type silver halide photographic light-sensitive material, which comprises at least one polyalkylene oxide or a derivative thereof. 1. A method for forming an ultra-high contrast negative image, comprising processing with a developer containing at least the following two components in the presence of: 2. The method for forming an ultra-high contrast negative image according to claim 1, wherein: (1) an aminophenol developing agent; (2) a reductone; and the reductone is a compound represented by the general formula [I] or a salt thereof. General formula I ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, R represents a hydrogen atom or a hydroxyl group, and n represents an integer from 1 to 4.) 3. Compounds in which reductones are represented by general formula [II] or The method for forming an ultra-high contrast negative image according to claim 1, which is a salt thereof. General formula II▲ Contains mathematical formulas, chemical formulas, tables, etc.▼
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4802290A JP2870939B2 (en) | 1990-02-28 | 1990-02-28 | Ultra-high contrast negative image forming method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4802290A JP2870939B2 (en) | 1990-02-28 | 1990-02-28 | Ultra-high contrast negative image forming method |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03249756A true JPH03249756A (en) | 1991-11-07 |
JP2870939B2 JP2870939B2 (en) | 1999-03-17 |
Family
ID=12791689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4802290A Expired - Lifetime JP2870939B2 (en) | 1990-02-28 | 1990-02-28 | Ultra-high contrast negative image forming method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2870939B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05165161A (en) * | 1991-12-17 | 1993-06-29 | Fuji Photo Film Co Ltd | Development processing method for silver halide photographic sensitive material |
US5648205A (en) * | 1994-10-13 | 1997-07-15 | Fuji Photo Film Co., Ltd. | Processing method for silver halide photographic material |
-
1990
- 1990-02-28 JP JP4802290A patent/JP2870939B2/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05165161A (en) * | 1991-12-17 | 1993-06-29 | Fuji Photo Film Co Ltd | Development processing method for silver halide photographic sensitive material |
US5648205A (en) * | 1994-10-13 | 1997-07-15 | Fuji Photo Film Co., Ltd. | Processing method for silver halide photographic material |
Also Published As
Publication number | Publication date |
---|---|
JP2870939B2 (en) | 1999-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2961850B2 (en) | Method for forming ultra-high contrast negative image | |
EP0480304B1 (en) | Silver halide photographic material and image forming process using the same | |
JPH0713304A (en) | Contrasty negative image forming method | |
JP2827455B2 (en) | Ultra-high contrast negative image forming method | |
JP2870939B2 (en) | Ultra-high contrast negative image forming method | |
JPS6147943A (en) | Silver halide photographic sensitive material | |
JP2514316B2 (en) | Silver halide photographic material | |
JP2926916B2 (en) | Ultra-high contrast negative image forming method using surface latent image type silver halide photographic light-sensitive material | |
JP3052479B2 (en) | Negative type silver halide photographic material and image forming method using the same | |
JP2961878B2 (en) | Photographic image forming method | |
JP2684714B2 (en) | Silver halide photographic light-sensitive material and method for forming high-contrast photographic image using the same | |
JPH0416938A (en) | Picture forming method | |
JP2906664B2 (en) | Photographic image forming method | |
JP3473827B2 (en) | Silver halide photographic materials | |
JP3298228B2 (en) | Photographic developer and method for forming a high contrast image using the same | |
JPH0237340A (en) | Silver halide photographic sensitive material capable of obtaining high contrast and high dot quality picture | |
JP3225688B2 (en) | Method for forming high contrast negative image, silver halide photographic light-sensitive material and photographic developer used therein | |
JPH01197739A (en) | Silver halide photographic sensitive material with high contrast | |
JPH02204740A (en) | Silver halide photographic sensitive material | |
JPH02287346A (en) | Silver halide photographic sensitive material and image forming method using the material | |
JPH0830864B2 (en) | Silver halide photographic light-sensitive material for plate making having improved reducing power and method for reducing the same | |
JPH0643603A (en) | Image-forming method and silver halide photographic sensitive matfterial to be used for same | |
JPH07110556A (en) | Contrast image forming method | |
JPH0380294B2 (en) | ||
JPH06123928A (en) | Silver halide photographic sensitive material and high-contrast image forming method using the same |